relented and agreed to part with the property. It was now a flagship holding of BMD.
He had an eye for design and he had loved remodeling the old mansion and making it into a modern clinic and research facility. He had renamed it the Dorian Institute and moved in Karl Van de Vliet and the research staff of the Gerex Corporation. He also had put a landing pad on the expansive roof, along with a stair leading down to an elevator that could take him directly to the laboratory in the basement.
Kenji Noda settled the McDonnell Douglas onto the pad and cut the engines. Bartlett never let himself worry about the noise. The patients in the clinical trials were here at no charge, so they really couldn't complain, particularly since they were now part of what was possibly turning out to be the greatest advance in the history of medicine. If your Alzheimer's had just been reversed at no charge, you weren't going to complain about a little hubbub on the roof.
'I'll wait here,' Noda said opening the side door. His bald pate, reminiscent of an eighteenth-century samurai, glistened in the early spring sun.
Bartlett nodded, knowing that his pilot did not trust physicians and hospitals. Taking care of your body was your responsibility, Kenji Noda frequently declared and he trained his own daily. He ate no meat and drank gallons of green tea. When he practiced
Bartlett headed down the metal stairs leading to the self-service elevator. This daily ordeal of flying out to give a blood sample and to see Kristen was increasingly unsettling. As he inserted his magnetic card into the elevator security box, he felt his hand shaking slightly.
So close to the eternal dream of humankind. So close. How was it going to end?
'Dr. Vee, I'm feeling so much better, I can't tell you.' Emma Rosen reached out and caught her physician by the collar of his lab coat, pulling him down and brazenly bussing his cheek. She'd been longing to do this for three weeks but hadn't mustered the nerve until now. 'This morning I climbed the stairs to the third floor, twice, up and back without any chest pain. Oy, can you believe? It's a miracle.'
Karl Van de Vliet was a couple of inches over six feet, with a trim face and sandy hair that some older patients judged too long for a physician. His English normally was perfect, though sometimes he made a mistake when trying to sound too colloquial. But everyone, young and old adored his retiring Dutch manner and those deep blue eyes that carried some monumental sadness from the past. They also were sure he would soon be recognized worldwide as the miracle worker he was. The prospect of a Nobel didn't actually seem that far-fetched.
'Emma, please, I begged you to rest.' He sighed and checked the dancing electronic pens of her EKG. They were in the basement of the Dorian Institute. Upstairs, the 'suites'-nobody called them rooms-were intended to invoke a spa more than a clinic, so most of the heavy-duty diagnostic equipment was kept in a row of examining rooms down near the subterranean lab. 'For another week at least. Why won't you listen? You've been a very naughty girl. I may have to tell your daughter.'
He glanced at the seventy-three-year-old woman's readout one last time, made a quick note on his handheld computer, and then laid a thin hand across her brow for a fleeting, subjective temperature check.
She's all but fully recovered, he told himself. It's truly astonishing.
Five weeks earlier, she had come through the front door of the Dorian Institute in a wheelchair pushed by her youngest, a bottle blonde named Shelly. He took one look and scuttled the normal security precautions, the frisk for cameras and recording devices. Emma's low cardiac output had deteriorated to the point that her left leg below the knee was swollen to almost twice its normal size, owing to renal retention of fluid, and she was so short of breath she required oxygen. He hadn't wanted to complicate the clinical trials by taking on another patient at that late date, but she had been referred by a physician friend in the city, begging. How could he turn her away?
He had removed a microscopic amount of bone marrow from her right ankle, extracted the stem cells, applied the hormonal signal that told them to develop into heart muscle, and then injected a thriving cell factory into her heart. Since stem cells could be made to ignore the body's rules to stop replicating after a certain number, they were able to reproduce forever, constantly renewing themselves. The only other cells with that immortal characteristic were cancer cells. In fact, it was as though he had given Emma a new kind of cancer-one that produced cells as healthy as those in a newborn. Today she probably could have run up those stairs.
Although his stem cell technology was going to create a new era in regenerative medicine, he had experienced his share of bumps in the road. Five years earlier, Stanford University had canceled his research project there since the work he had been doing involved the special stem cells in unused fertility-clinic embryos. The university claimed there had been death threats to its president. The Board of Regents had finally decided with a sham show of remorse, to revoke his funding. They called him in one sunny afternoon in May and pulled the plug. He thanked them and tore up his contract. By that time he had already demonstrated that, using the right chemical signals, stem cells could be coaxed into becoming almost any organ. Inserted into the heart, they became new heart muscle, replacing scars; inserted into the brain, they became neural tissue. No way was he going to be stopped now. They didn't know what they were losing.
What he needed was a 'white knight.' He did some poking around and came up with Winston Bartlett, then floated feelers to Bartlett's people. What if, he proposed, Bartlett acquired the Gerex Corporation for BMD and made it a for-profit business? No more public funding (and maddening administrative meddling). The research already completed was so close to a payoff, after years and years of grinding lab work and thousands of white mice, that the deal could be considered an investment where 95 percent of the seed money had already been supplied by taxpayers.
Winston Bartlett had liked the sound of that, and Karl Van de Vliet had his white knight.
Once his financing was secure, he decided to begin by solving the problem that had dogged him at Stanford. Since there would always be a distracting public-relations problem hounding any researcher in the United States who made use of aborted embryos, even if it was to save lives, he was determined to find a less controversial way to trick Mother Nature and garner 'pluripotent' stem cells, the name given those that could give rise to virtually any tissue type.
He had. After he moved his research team into the Dorian Institute just over 4 1/2 years ago, he had perfected a way to use a human protein, an enzyme called telomerase, to make adult stem cells do most of the miracles once only thought possible with embryonic cells.
The phase-three clinical trials over the past seven months had proved conclusively that the technique worked. Adult stem cells, when treated with the telomerase enzyme to arrest the process of cell senescence, could indeed regenerate everything from the human brain to the human heart, from Parkinson's to acute myocardial infarction.
Twenty-three days from now, when the phase-three clinical trials were formally scheduled to be completed, Karl Van de Vliet would have enough data for the National Institutes of Health to confirm one of the most important breakthroughs in the history of medicine.
Unfortunately, however, there was that other bit of data that he would not be sharing with the NIH. The Beta.
Thinking about that, his heart heavy, he turned back to the situation at hand.
'Emma, you're making wonderful progress,' he continued on with the banter, 'but don't push yourself too hard just yet.'
She laughed, sending lines across her forehead. Her voice was deep and rich, sultry in its own way. 'When you get as old as I am, honey, you do anything you can get away with. What am I saving it for? I just might go to Atlantic City next week and pick up a sailor.'
'Well, then, I may have to have Shelly go along and keep an eye on you,' he said with one last programmed smile. Then he checked his watch. Bartlett should be arriving any minute now. Time to get Emma Rosen the hell out of here and back upstairs.
He turned and signaled for Ellen O'Hara, the head nurse, to start removing the suction-cup electrodes that had been stuck on Emma for her EKG. Ellen had been with him when he was at Stanford and her loyalty was unquestioned. She had made sure that the Beta disaster with Kristen hadn't become the gossip of the institute. Still, how much longer could it be kept quiet?
